Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Sani H. Kizilbash | Researchclopedia

Back to researchers

Sani H. Kizilbash

Mayo Clinic ORCID

219

Works

2,076

Citations

19

h-index

38

i10-index

Research Topics

Glioma Diagnosis and Treatment PARP inhibition in cancer therapy Brain Metastases and Treatment

Affiliations

Mayo Clinic2013–2025

WinnMed2013–2025

Research Institute of Radiology2023–2023

University of Minnesota Rochester2023–2024

Mayo Clinic in Arizona2012–2025

Top Works

Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

Jann N. Sarkaria,Leland Hu,et al.

2017676 citations

Cancer, Hypoxia, and Metabolism

Cancer Genomics and Diagnostics

Delineation of<i>MGMT</i>Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma

Shiv K. Gupta,Sani H. Kizilbash,et al.

2015120 citations

Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System

Karen E. Parrish,Ling Cen,et al.

201587 citations

PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity

Shiv K. Gupta,Emily J. Smith,et al.

201979 citations

Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine

Minjee Kim,Sani H. Kizilbash,et al.

201879 citations

Discordant <i>In Vitro</i> and <i>In Vivo</i> Chemopotentiating Effects of the PARP Inhibitor Veliparib in Temozolomide-Sensitive versus -Resistant Glioblastoma Multiforme Xenografts

Shiv K. Gupta,Ann C. Mladek,et al.

201477 citations

Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma

Sani H. Kizilbash,Shiv K. Gupta,et al.

201773 citations

The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study

Andres Ramos‐Fresnedo,Michael W. Pullen,et al.

202272 citations

Initial Results of a Phase 2 Trial of 18F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma

Nadia N. Laack,Deanna Pafundi,et al.

202165 citations